These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7516662)

  • 1. Mapping of antigenic and immunogenic sites of Haemophilus influenzae outer membrane protein P6 using synthetic lipopeptides.
    Beck-Sickinger AG; Rotering H; Wiesmüller KH; Dorner F; Jung G
    Biol Chem Hoppe Seyler; 1994 Mar; 375(3):173-82. PubMed ID: 7516662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
    Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
    Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae.
    Bogdan JA; Apicella MA
    Infect Immun; 1995 Nov; 63(11):4395-401. PubMed ID: 7591076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
    McMahon M; Murphy TF; Kyd J; Thanavala Y
    Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of outer membrane protein P6, a vaccine antigen of non-typeable Haemophilus influenzae.
    Karalus RJ; Murphy TF
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):159-66. PubMed ID: 10536303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of non-typeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion.
    Harabuchi Y; Murakata H; Goh M; Kodama H; Kataura A; Faden H; Murphy TF
    Acta Otolaryngol; 1998 Nov; 118(6):826-32. PubMed ID: 9870628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms.
    Nelson MB; Munson RS; Apicella MA; Sikkema DJ; Molleston JP; Murphy TF
    Infect Immun; 1991 Aug; 59(8):2658-63. PubMed ID: 1713197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine candidate P6 of nontypable Haemophilus influenzae is not a transmembrane protein based on protein structural analysis.
    Michel LV; Kalmeta B; McCreary M; Snyder J; Craig P; Pichichero ME
    Vaccine; 2011 Feb; 29(8):1624-7. PubMed ID: 21215345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
    Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
    Hotomi M; Saito T; Yamanaka N
    Vaccine; 1998 Dec; 16(20):1950-6. PubMed ID: 9796049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein.
    Nomura Y; Abe Y; Ishida Y; Kobayashi H; Harabuchi Y
    J Clin Immunol; 2008 Jul; 28(4):361-9. PubMed ID: 18379862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae.
    Murphy TF; Bartos LC; Campagnari AA; Nelson MB; Apicella MA
    Infect Immun; 1986 Dec; 54(3):774-9. PubMed ID: 3491049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses.
    Badr WH; Loghmanee D; Karalus RJ; Murphy TF; Thanavala Y
    Vaccine; 1999 Aug; 18(1-2):29-37. PubMed ID: 10501232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human T-cell epitopes and highly immunogenic analog peptides on the non-typeable Haemophilus influenzae P6 outer membrane protein.
    Ishida Y; Abe Y; Yanai M; Kobayashi H; Harabuchi Y
    Clin Immunol; 2006 Oct; 121(1):90-9. PubMed ID: 16901757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
    Evenberg D; Hoogerhout P; van Boeckel CA; Rijkers GT; Beuvery EC; van Boom JH; Poolman JT
    J Infect Dis; 1992 Jun; 165 Suppl 1():S152-5. PubMed ID: 1588151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of B-cell epitopes on the outer membrane P2 porin protein of Haemophilus influenzae by using recombinant proteins and synthetic peptides.
    Martin D; Munson R; Grass S; Chong P; Hamel J; Zobrist G; Klein M; Brodeur BR
    Infect Immun; 1991 Apr; 59(4):1457-64. PubMed ID: 1706322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae.
    Duim B; Vogel L; Puijk W; Jansen HM; Meloen RH; Dankert J; van Alphen L
    Infect Immun; 1996 Nov; 64(11):4673-9. PubMed ID: 8890224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.